Paediatric Drug Product Development Through To Commercialisation

Developing medicines for pediatric patients requires a careful balance between formulation performance, patient acceptance and commercial manufacturability. As regulatory expectations continue to drive demand for age-appropriate drug products, pharmaceutical companies are increasingly exploring alternative dosage forms that improve administration while supporting scalability and long-term supply.

When a leading pharmaceutical company sought to develop a pediatric treatment, the goal was to create an easy-to-administer dosage form that would meet patient needs while remaining suitable for routine commercial manufacture. The project involved designing a minitablet-in-stickpack presentation, addressing challenges associated with tablet compression, dose accuracy, equipment selection and downstream packaging processes. Through close collaboration, specialized engineering solutions and integrated development and commercialization expertise, the team established a robust manufacturing and filling process capable of supporting commercial supply.

Discover how strategic formulation development, innovative process design and early commercialization planning helped transform a pediatric drug concept into a scalable product designed to support both patient adherence and long-term market success.